OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+1.81%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$326M
AUM Growth
+$326M
(-34%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-50.86%
Top 10 Holdings %
Top 10 Hldgs %
94.39%
Holding
31
New
5
Increased
5
Reduced
10
Closed
6
Top Buys
| 1 |
Moderna
MRNA
|
$12.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11.7M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
$3.6M |
| 4 |
GeneDx Holdings
WGS
|
$3.33M |
| 5 |
IMMP
Immutep
IMMP
|
$1.18M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$120M |
| 2 |
QuidelOrtho
QDEL
|
$20.3M |
| 3 |
ARK Innovation ETF
ARKK
|
$16.6M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$11.8M |
| 5 |
AGEN
Agenus
AGEN
|
$7.86M |
Sector Composition
| 1 | Healthcare | 98.7% |
| 2 | Energy | 0.18% |
| 3 | Industrials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $181M | 54.93% | 1,240,932 -820,470 | -40% | -$120M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $48.5M | 14.74% | 499,263 -209,368 | -30% | -$20.3M |
|
3
Opko Health
OPK
$1.1B
| $18.3M | 5.57% | 7,252,756 -1,733,000 | -19% | -$4.38M |
|
|
4
Moderna
MRNA
$9.37B
| $12.8M | 3.89% | +89,700 | New | +$12.8M |
|
|
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.7M | 3.57% | +175,000 | New | +$11.7M |
|
|
AGEN
6
Agenus
AGEN
$133M
| $9.03M | 2.74% | 4,656,132 -4,050,000 | -47% | -$7.86M |
|
|
7
GeneDx Holdings
WGS
$3.72B
| $8.3M | 2.52% | 6,585,354 +2,640,522 | +67% | +$3.33M |
|
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.39M | 1.94% | 603,994 -1,116,739 | -65% | -$11.8M |
|
|
CFRX
9
DELISTED
ContraFect Corporation
CFRX
| $6.05M | 1.84% | 1,969,222 +15,000 | +0.8% | +$46.1K |
|
10
Forian
FORA
$61.3M
| $5.85M | 1.78% | 1,333,477 +71,437 | +6% | +$314K |
|
|
11
ProShares UltraPro QQQ
TQQQ
$26B
| $3.6M | 1.09% | +150,000 | New | +$3.6M |
|
12
Pacific Biosciences
PACB
$393M
| $3.55M | 1.08% | 803,845 -421,550 | -34% | -$1.86M |
|
|
IMMP
13
Immutep
IMMP
$234M
| $3.16M | 0.96% | 1,557,325 +581,169 | +60% | +$1.18M |
|
|
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
| $2.43M | 0.74% | 2,445,791 -286,065 | -10% | -$284K |
|
|
DMTK
15
DELISTED
DermTech, Inc. Common Stock
DMTK
| $1.37M | 0.42% | 246,569 -406,338 | -62% | -$2.25M |
|
|
CDAK
16
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $1.34M | 0.41% | 463,998 -40,604 | -8% | -$117K |
|
|
PNT
17
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $884K | 0.27% | +129,810 | New | +$884K |
|
|
VTNR
18
DELISTED
Vertex Energy, Inc
VTNR
| $598K | 0.18% | 56,800 +1,800 | +3% | +$19K |
|
19
Biogen
BIIB
$19.4B
| $492K | 0.15% | 2,412 | – | – |
|
|
AWH
20
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $428K | 0.13% | 728,100 -1,388,739 | -66% | -$816K |
|
21
Soleno Therapeutics
SLNO
$3.6B
| $394K | 0.12% | 2,132,000 | – | – |
|
|
VLD
22
DELISTED
Velo3D, Inc.
VLD
| $42K | 0.01% | +30,379 | New | +$42K |
|
23
Arbutus Biopharma
ABUS
$711M
| – | – | -50,000 | Closed | -$149K |
|
24
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -186,789 | Closed | -$4.52M |
|
|
25
ARK Innovation ETF
ARKK
$7.45B
| – | – | -250,000 | Closed | -$16.6M |
|